During the past decade, Senti Tech conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Senti Tech" #1 collaborator was "Liverpool University Hospitals NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Senti Tech" are "Covid19" (1 trials) and "Respiratory Disease" (1 trials). Many other conditions were trialed in "Senti Tech" in a lesser frequency.

Most popular intervention types in "Senti Tech" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Senti V1.0 Device" (2 trials). Other intervention names were less common.

The vast majority of trials in "Senti Tech" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Senti Tech". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Senti Tech, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Senti Tech, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".